Form 8-K - Current report:
SEC Accession No. 0000950170-22-023528
Filing Date
2022-11-09
Accepted
2022-11-09 08:29:41
Documents
63
Period of Report
2022-11-09
Items
Item 2.02: Results of Operations and Financial Condition
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K clsd-20221109.htm   iXBRL 8-K 72251
2 EX-99.1 clsd-ex99_1.htm EX-99.1 182445
3 EX-99.2 clsd-ex99_2.htm EX-99.2 63435
4 EX-99.3 clsd-ex99_3.htm EX-99.3 41929
5 GRAPHIC img171462827_0.jpg GRAPHIC 9379
6 GRAPHIC img172386348_0.jpg GRAPHIC 6360
7 GRAPHIC img172386348_1.jpg GRAPHIC 127789
8 GRAPHIC clsd-ex99_3s1.jpg GRAPHIC 76815
9 GRAPHIC clsd-ex99_3s2.jpg GRAPHIC 158183
10 GRAPHIC clsd-ex99_3s3.jpg GRAPHIC 71736
11 GRAPHIC clsd-ex99_3s4.jpg GRAPHIC 70379
12 GRAPHIC clsd-ex99_3s5.jpg GRAPHIC 91018
13 GRAPHIC clsd-ex99_3s6.jpg GRAPHIC 104137
14 GRAPHIC clsd-ex99_3s7.jpg GRAPHIC 91638
15 GRAPHIC clsd-ex99_3s8.jpg GRAPHIC 62439
16 GRAPHIC clsd-ex99_3s9.jpg GRAPHIC 61132
17 GRAPHIC clsd-ex99_3s10.jpg GRAPHIC 60042
18 GRAPHIC clsd-ex99_3s11.jpg GRAPHIC 112862
19 GRAPHIC clsd-ex99_3s12.jpg GRAPHIC 110318
20 GRAPHIC clsd-ex99_3s13.jpg GRAPHIC 77388
21 GRAPHIC clsd-ex99_3s14.jpg GRAPHIC 100619
22 GRAPHIC clsd-ex99_3s15.jpg GRAPHIC 103664
23 GRAPHIC clsd-ex99_3s16.jpg GRAPHIC 58597
24 GRAPHIC clsd-ex99_3s17.jpg GRAPHIC 78184
25 GRAPHIC clsd-ex99_3s18.jpg GRAPHIC 67502
26 GRAPHIC clsd-ex99_3s19.jpg GRAPHIC 47588
27 GRAPHIC clsd-ex99_3s20.jpg GRAPHIC 48235
28 GRAPHIC clsd-ex99_3s21.jpg GRAPHIC 66438
29 GRAPHIC clsd-ex99_3s22.jpg GRAPHIC 73410
30 GRAPHIC clsd-ex99_3s23.jpg GRAPHIC 61699
31 GRAPHIC clsd-ex99_3s24.jpg GRAPHIC 90968
32 GRAPHIC clsd-ex99_3s25.jpg GRAPHIC 78897
33 GRAPHIC clsd-ex99_3s26.jpg GRAPHIC 70034
34 GRAPHIC clsd-ex99_3s27.jpg GRAPHIC 79322
35 GRAPHIC clsd-ex99_3s28.jpg GRAPHIC 65784
36 GRAPHIC clsd-ex99_3s29.jpg GRAPHIC 133446
37 GRAPHIC clsd-ex99_3s30.jpg GRAPHIC 50568
38 GRAPHIC clsd-ex99_3s31.jpg GRAPHIC 43756
39 GRAPHIC clsd-ex99_3s32.jpg GRAPHIC 70265
40 GRAPHIC clsd-ex99_3s33.jpg GRAPHIC 60177
41 GRAPHIC clsd-ex99_3s34.jpg GRAPHIC 89254
42 GRAPHIC clsd-ex99_3s35.jpg GRAPHIC 82754
43 GRAPHIC clsd-ex99_3s36.jpg GRAPHIC 98414
44 GRAPHIC clsd-ex99_3s37.jpg GRAPHIC 100624
45 GRAPHIC clsd-ex99_3s38.jpg GRAPHIC 87341
46 GRAPHIC clsd-ex99_3s39.jpg GRAPHIC 69830
47 GRAPHIC clsd-ex99_3s40.jpg GRAPHIC 72951
48 GRAPHIC clsd-ex99_3s41.jpg GRAPHIC 86819
49 GRAPHIC clsd-ex99_3s42.jpg GRAPHIC 67210
50 GRAPHIC clsd-ex99_3s43.jpg GRAPHIC 75055
51 GRAPHIC clsd-ex99_3s44.jpg GRAPHIC 67342
52 GRAPHIC clsd-ex99_3s45.jpg GRAPHIC 105676
  Complete submission text file 0000950170-22-023528.txt   5673903

Data Files

Seq Description Document Type Size
53 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT clsd-20221109_pre.xml EX-101.PRE 9843
54 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT clsd-20221109.xsd EX-101.SCH 2469
55 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT clsd-20221109_lab.xml EX-101.LAB 13360
57 EXTRACTED XBRL INSTANCE DOCUMENT clsd-20221109_htm.xml XML 4717
Mailing Address 900 NORTH POINT PARKWAY SUITE 200 ALPHARETTA GA 30005
Business Address 900 NORTH POINT PARKWAY SUITE 200 ALPHARETTA GA 30005 678-270-3631
Clearside Biomedical, Inc. (Filer) CIK: 0001539029 (see all company filings)

EIN.: 452437375 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37783 | Film No.: 221370773
SIC: 2834 Pharmaceutical Preparations